February 20, 2026

Survival Outcomes With or Without Bilateral Risk-Reducing Mastectomy in BRCA1/BRCA2 Pathogenic Variant Carriers

In a UK study reported in the Journal of Clinical Oncology, Gandhi et al found that whereas breast cancer incidence was reduced with bilateral risk-reducing mastectomy among women carrying BRCA1/BRCA2...

The ASCO Post

February 20, 2026

CLL/SLL: FDA Approves Combination of Acalabrutinib and Venetoclax

The ASCO Post

February 20, 2026

AI Tool Classifies Pediatric Brain Tumors via Liquid Biopsy

The ASCO Post

February 19, 2026

High Response Rates With Front-Line Pivekimab Sunirine in BPDCN

The ASCO Post

April 15, 2026

Is Standard of Care Optimal for the Individual Patient?

The ASCO Post

April 15, 2026

Dana-Farber Research News 04.15.2026

Dana-Farber

The Myelofibrosis Journey From Diagnosis to Long-Term Management

This new program delivers concise, expert-informed education to guide decision-making across all stages of myelofibrosis (MF) care.

Explore the Resource

Latest Headlines

April 15, 2026

Is Standard of Care Optimal for the Individual Patient?

The ASCO Post

April 15, 2026

Dana-Farber Research News 04.15.2026

Dana-Farber

April 15, 2026

LuPSMA-617 and Pembrolizumab in mCRPC

The ASCO Post

April 14, 2026

Join Roswell Park at AACR 2026

Roswell Park Comprehensive Cancer Center

April 14, 2026

PSMA PET/CT Scan Reduces Need for Prostate Cancer Biopsies by 50%

The ASCO Post

April 14, 2026

Surgery Still Safe, Beneficial For Many Octogenarian Patients With NSCLC

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

EBCC15

April 13, 2026

Elinzanetant May Reduce Side Effects of Endocrine Therapy Among Patients With Breast Cancer

The ASCO Post

April 01, 2026

Early Results From a Trial of Active Surveillance for Low-Risk DCIS are ‘Reassuring,’ Say Researchers

The ASCO Post

March 30, 2026

Radiotherapy May Reduce Risk of Lymphedema in Patients With Breast Cancer More Effectively Than Surgery

The ASCO Post

2026 ASCO GU

April 10, 2026

Combined Tests Could Avoid Unnecessary Cystectomy, Study Finds

The ASCO Post

April 07, 2026

Can ctDNA Negativity Predict Metastasis-Free Survival in Muscle-Invasive Bladder Cancer?

The ASCO Post

April 07, 2026

Neoadjuvant/Adjuvant Doublet Significantly Improved Survival in Patients With Muscle-Invasive Bladder Cancer

The ASCO Post

2026 ASCO GI

April 03, 2026

Study Finds GLP-1RAs Were Associated With a Reduced Risk of Developing Colorectal Cancer vs Aspirin

The ASCO Post

April 01, 2026

Activity Observed With Novel KRAS Inhibitor in Pancreatic Cancer

The ASCO Post

March 24, 2026

No Recurrence-Free Survival Benefit With Adjuvant Pembrolizumab in Hepatocellular Carcinoma

The ASCO Post

Clinical Guidelines

April 15, 2026

LuPSMA-617 and Pembrolizumab in mCRPC

The ASCO Post

April 14, 2026

PSMA PET/CT Scan Reduces Need for Prostate Cancer Biopsies by 50%

The ASCO Post

April 14, 2026

Surgery Still Safe, Beneficial For Many Octogenarian Patients With NSCLC

The ASCO Post

April 13, 2026

Electroacupuncture May Relieve Cognitive, Psychological Symptoms in Breast Cancer Survivors in Pilot Study

The ASCO Post

Commentary & Perspectives

April 15, 2026

Is Standard of Care Optimal for the Individual Patient?

The ASCO Post

April 09, 2026

In Celebration of a Decades-Long Journey of Discovery and Innovation

The ASCO Post

March 31, 2026

‘Prostate Screening Saved My Life’—Is That Really True in Most Cases?

The ASCO Post

March 25, 2026

How to Increase Organ Donations in the U.S.: Education and Financial Aid Are Key

Keck Medicine of USC

FDA & Government News

March 24, 2026

FDA Approves Teclistamab and Daratumumab For Relapsed or Refractory Multiple Myeloma

The ASCO Post

March 23, 2026

FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma

The ASCO Post

August 29, 2023

FDA Approves Luspatercept-aamt as First-Line Treatment for Adult Patients With Lower-Risk MDS and Anemia Who May Require Transfusions

The ASCO Post

January 25, 2021

FDA Approves First Oral Hormone Therapy for Treating Advanced Prostate Cancer

The ASCO Post

Business Management

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

April 10, 2025

American Cancer Society Launches CEO Search

The ASCO Post

January 29, 2025

Clinical Posters From JADPRO Live 2024

JADPRO

November 05, 2025

How a $2 Billion Gift to the Knight Cancer Institute May Accelerate Cancer Advances and Streamline Care for Patients

The ASCO Post

Trending Now

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

The New Optometrist

The Pathologist

High Response Rates With Front-Line Pivekimab Sunirine in BPDCN

Is Standard of Care Optimal for the Individual Patient?

Dana-Farber Research News 04.15.2026

Latest Headlines

Daily News

Recommendations

Trending Now

1

Strategy for Managing Immunotherapy-Induced Parkinsonism in Patients With Multiple Myeloma

Featured Videos

Conference Coverage

EBCC15

2026 ASCO GU

2026 ASCO GI

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management